Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 12251-12300 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04252235
Home Air Purification for Eosinophilic COPD
NAActive, not recruiting
178 participants
Started: Mar 15, 2021 · Completed: Jan 30, 2026
2 conditions2 sponsors1 location
NCT04573920
Atrasentan in Patients With Proteinuric Glomerular Diseases
PHASE2Active, not recruiting
103 participants
Started: Mar 15, 2021 · Completed: Oct 27, 2026
6 conditions1 sponsor33 locations
NCT04578938
Ketamine + Cognitive Training for Suicidality in the Medical Setting
PHASE4Active, not recruiting
200 participants
Started: Mar 15, 2021 · Completed: Mar 2, 2026
1 condition2 sponsors1 location
NCT04488861
The START Clinic: a Feasibility Study
N/AActive, not recruiting
120 participants
Started: Mar 15, 2021 · Completed: Sep 30, 2024
5 conditions4 sponsors1 location
NCT04498754
An Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder
NAActive, not recruiting
140 participants
Started: Mar 15, 2021 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT04580927
Breastfeeding and Postpartum Cardiovascular Health
NAActive, not recruiting
221 participants
Started: Mar 15, 2021 · Completed: Nov 30, 2025
5 conditions3 sponsors4 locations
NCT04811846
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
NAActive, not recruiting
40 participants
Started: Mar 14, 2021 · Completed: Oct 31, 2025
5 conditions2 sponsors2 locations
NCT05035173
The LYSA (Linking You to Support and Advice) Trial
NAActive, not recruiting
200 participants
Started: Mar 13, 2021 · Completed: Dec 31, 2025
4 conditions9 sponsors1 location
NCT04591392
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
NAActive, not recruiting
250 participants
Started: Mar 12, 2021 · Completed: Mar 31, 2032
7 conditions1 sponsor32 locations
NCT04798235
First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis
PHASE1/PHASE2Active, not recruiting
3 participants
Started: Mar 12, 2021 · Completed: Mar 12, 2027
1 condition3 sponsors1 location
NCT05346198
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
PHASE1Active, not recruiting
15 participants
Started: Mar 12, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT04712643
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
PHASE3Active, not recruiting
342 participants
Started: Mar 12, 2021 · Completed: Feb 1, 2029
1 condition1 sponsor40 locations
NCT04751773
Postoperative Exercise Training in Patients With Colorectal Liver Metastases Undergoing Surgery (ELMA)
NAActive, not recruiting
60 participants
Started: Mar 12, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06555978
Ageing BIOmarker Study in Singaporeans
N/AActive, not recruiting
420 participants
Started: Mar 12, 2021 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT04661150
A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction
PHASE2Active, not recruiting
42 participants
Started: Mar 12, 2021 · Completed: Jul 30, 2026
2 conditions1 sponsor8 locations
NCT04800367
Romosozumab/Denosumab Study for Premenopausal IOP
PHASE2Active, not recruiting
31 participants
Started: Mar 12, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT04921670
Infliximab Proactive Drug Monitoring in the Pediatric IBD Population
N/AActive, not recruiting
60 participants
Started: Mar 12, 2021 · Completed: Aug 30, 2025
1 condition1 sponsor1 location
NCT04747340
Clinical Effectiveness of TARA Compared to Standard Treatment for Adolescents and Young Adults With Depression
NAActive, not recruiting
136 participants
Started: Mar 12, 2021 · Completed: Jan 1, 2029
3 conditions3 sponsors3 locations
NCT04722146
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
PHASE1Active, not recruiting
140 participants
Started: Mar 12, 2021 · Completed: Oct 5, 2027
1 condition1 sponsor27 locations
NCT04562389
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
PHASE3Active, not recruiting
353 participants
Started: Mar 11, 2021 · Completed: Mar 31, 2028
1 condition1 sponsor166 locations
NCT04729933
Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
NAActive, not recruiting
10 participants
Started: Mar 11, 2021 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT04772911
Multicenter Phenotype-Genotype Analysis of Vascular Stains to Optimize Treatment Utilizing Optical Coherence Tomography
N/AActive, not recruiting
73 participants
Started: Mar 11, 2021 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations
NCT04062708
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
38 participants
Started: Mar 10, 2021 · Completed: Jul 31, 2026
2 conditions2 sponsors9 locations
NCT04765488
WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane
NAActive, not recruiting
200 participants
Started: Mar 10, 2021 · Completed: Feb 25, 2026
3 conditions1 sponsor3 locations
NCT04731363
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
NAActive, not recruiting
50 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04731688
A Weight Maintenance Program Promoting Fat Loss in Pregnancy in Women With Obesity
NAActive, not recruiting
100 participants
Started: Mar 10, 2021 · Completed: Dec 30, 2026
2 conditions4 sponsors2 locations
NCT04839523
Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns
NAActive, not recruiting
44 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor6 locations
NCT04714762
eHealth in Treatment of Gestational Diabetes (eMOMGDM)
NAActive, not recruiting
200 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2026
2 conditions9 sponsors1 location
NCT04742101
Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
57 participants
Started: Mar 10, 2021 · Completed: Dec 30, 2025
1 condition2 sponsors11 locations
NCT04756648
Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma
PHASE1Active, not recruiting
21 participants
Started: Mar 10, 2021 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT04874493
Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer
N/AActive, not recruiting
77 participants
Started: Mar 10, 2021 · Completed: Feb 2, 2027
1 condition1 sponsor1 location
NCT03937830
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma
PHASE2Active, not recruiting
27 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT02735083
A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19
PHASE1Active, not recruiting
28 participants
Started: Mar 10, 2021 · Completed: Sep 30, 2028
1 condition2 sponsors16 locations
NCT04398082
TRANslating Sleep Health Into QUaLity of Recovery (TRANQUiL) Study
N/AActive, not recruiting
174 participants
Started: Mar 10, 2021 · Completed: Jan 31, 2026
2 conditions2 sponsors2 locations
NCT04640025
A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib
PHASE2Active, not recruiting
18 participants
Started: Mar 10, 2021 · Completed: Jun 22, 2026
3 conditions1 sponsor21 locations
NCT03821142
Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair
NAActive, not recruiting
180 participants
Started: Mar 10, 2021 · Completed: Oct 31, 2029
1 condition1 sponsor6 locations
NCT04531046
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
PHASE2Active, not recruiting
62 participants
Started: Mar 10, 2021 · Completed: Jun 30, 2026
2 conditions1 sponsor16 locations
NCT04617314
A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors
PHASE1Active, not recruiting
32 participants
Started: Mar 10, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT04666038
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
PHASE3Active, not recruiting
238 participants
Started: Mar 9, 2021 · Completed: May 31, 2027
2 conditions2 sponsors232 locations
NCT05019456
Exercise and COVID-19 Viral T-cell Immunity
NAActive, not recruiting
26 participants
Started: Mar 9, 2021 · Completed: Dec 25, 2025
2 conditions1 sponsor1 location
NCT04882891
Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.
NAActive, not recruiting
80 participants
Started: Mar 9, 2021 · Completed: Feb 15, 2026
1 condition3 sponsors7 locations
NCT04727723
Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs
N/AActive, not recruiting
164 participants
Started: Mar 9, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor18 locations
NCT04643574
NeoTIL in Advanced Solid Tumors
PHASE1Active, not recruiting
42 participants
Started: Mar 9, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT04794634
Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers
NAActive, not recruiting
55 participants
Started: Mar 9, 2021 · Completed: Sep 1, 2025
8 conditions1 sponsor1 location
NCT04540302
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
NAActive, not recruiting
357 participants
Started: Mar 9, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor43 locations
NCT05682872
Multifactorial Fall Prevention Program
NAActive, not recruiting
264 participants
Started: Mar 9, 2021 · Completed: Nov 9, 2026
1 condition6 sponsors1 location
NCT04321954
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
PHASE2Active, not recruiting
30 participants
Started: Mar 9, 2021 · Completed: Nov 13, 2026
2 conditions2 sponsors3 locations
NCT04618016
Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
N/AActive, not recruiting
605 participants
Started: Mar 8, 2021 · Completed: Oct 31, 2034
5 conditions3 sponsors8 locations
NCT04722354
Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity
PHASE2Active, not recruiting
48 participants
Started: Mar 8, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04844073
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
PHASE1/PHASE2Active, not recruiting
97 participants
Started: Mar 8, 2021 · Completed: Nov 1, 2026
3 conditions1 sponsor27 locations